
|Articles|November 2, 2020
Pharmacy Times: Week of November 2 Lineup
This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.
Advertisement
This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week, including:
- A video interview with Ned Milenkovich, principal and co-chair of the Health Care Law practice group at Much Shelist, about how federal and state law may affect vaccine administration in accordance with recent declarations by the US Department of Health and Human Services (HHS) authorizing pharmacists to administer vaccines to children during the coronavirus disease 2019 (COVID-19) pandemic and to order and administer an eventual COVID-19 vaccine once it’s available.
- On Wednesday, Pharmacy Times will publish a clinical review of new migraine drugs that target the triptan contraindication population.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Zidesamtinib for Previously Treated ROS1-Positive NSCLC
2
Navigating REMS: Challenges, Perspectives, and the Path Forward for Bispecific Antibody Programs
3
mRNA COVID-19 Booster Outperforms Protein-Based Shot on Antibodies, But Both Cut Infections Over 12 Months
4
Glargine Insulin Linked to Fewer Severe Lows in Youth With T1D
5


































































































